ISRG Intuitive Surgical Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: ISRG
  4. Earnings
?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 18
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 91

EPS in 2026 (TTM): $8.36

Last Report Period Date: Mar 31, 2026

Currently, ISRG's 12-month EPS stands at $8.36, according to the most recent financial reports. Intuitive Surgical's earnings per share in 2025 was reported at $8, marking a rise from $6.54 in 2024. ISRG recorded an EPS of $2.31 for the quarterly period ending on Mar 31, 2026.

ISRG earnings history

Historical annual and quarterly earnings per share (EPS) data for Intuitive Surgical
EPS (TTM)
$8.36
EPS Growth YoY (Quarterly)
18.5%
EPS (Quarterly)
$2.31
EPS Growth (Quarterly)
3.6%

In 2025, Intuitive Surgical's earnings per share was $8, a rise of 22.3% from $6.54 in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $2.31, showing a 18.5% increase compared to the same quarter last year. The trailing twelve months EPS for ISRG is $8.36 as of March 2026. Intuitive Surgical's full-year EPS for 2024 was $6.54, a 27.7% rise compared to the previous year.

ISRG earnings chart

ISRG EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
18.5%
EPS growth YoY
22.3%
EPS growth 3Y avg
29.1%
EPS growth 5Y avg
21.5%

Over the past 12 months, Intuitive Surgical has recorded an earnings per share growth rate of 18.5% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 29.1% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of 21.5%. A ten-year view shows that ISRG has seen an average earnings per share growth of 16.3% per year.

ISRG Earnings Waterfall

Breakdown of revenue, profit and net income for Intuitive Surgical

ISRG Earnings vs Peers

What are the earnings of ISRG compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
CNMD CONMED Corp 18.56 -64.6% N/A 35.7%
BSX Boston Scientific Corp 18.71 55.6% 63.3% N/A
MDT Medtronic plc 21.38 3.3% 9.8% 6.9%
JNJ Johnson & Johnson 27.05 90.6% 17.7% 14.8%
SYK Stryker Corp 35.35 8% 10.9% 14.8%
BDX Becton Dickinson & Co 36.16 -0.9% -0.6% 16.2%
IDXX Idexx Laboratories Inc 39.88 22.3% 17.5% 14.1%
ISRG Intuitive Surgical Inc 48.27 22.3% 29.1% 21.5%
TFX Teleflex Inc N/A -1,462.4% N/A N/A
BAX Baxter International Inc N/A -47.2% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.